Multidrug-resistant Escherichia coli bacteremia in cancer patients
Karen J. Vigil(Texas Medical Center), I. Raad(The University of Texas MD Anderson Cancer Center), Ray Hachem(The University of Texas MD Anderson Cancer Center), Jeffrey J. Tarrand, Javier A. Adachi(The University of Texas MD Anderson Cancer Center), Halim Aboufaycal(The University of Texas MD Anderson Cancer Center), Roy F. Chemaly(The University of Texas MD Anderson Cancer Center), Gerald P. Bodey(Unknown), Ying Jiang(The University of Texas MD Anderson Cancer Center), Kenneth V. I. Rolston(CancerCare Manitoba), Ruth Reitzel(The University of Texas MD Anderson Cancer Center)
Cited by 28
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
|New England Journal of Medicine|1999|806
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
|Clinical Infectious Diseases|2006|752
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
|Journal of Clinical Oncology|2018|574
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
|Clinical Infectious Diseases|1997|426